Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial

Introduction: In India, the routine Active Management of ThirdStage of Labour (AMTSL) with conventional intramuscular oxytocin, at the rural, resource-constrained areas, is often compromised due to lack of trained healthcare personnel and proper maintenance of cold chain system, causing maternal...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sougata Kumar Burman, Ritwik Samanta, Kumari Kanak Lata, Jayeeta Mukherjee, Tapan Kumar Dey
Formato: article
Lenguaje:EN
Publicado: JCDR Research and Publications Private Limited 2021
Materias:
R
Acceso en línea:https://doaj.org/article/d721309ec20d4a05bf399ce27b7477d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d721309ec20d4a05bf399ce27b7477d3
record_format dspace
spelling oai:doaj.org-article:d721309ec20d4a05bf399ce27b7477d32021-11-12T12:21:30ZProphylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial10.7860/JCDR/2021/50020.153872249-782X0973-709Xhttps://doaj.org/article/d721309ec20d4a05bf399ce27b7477d32021-09-01T00:00:00Zhttps://www.jcdr.net/articles/PDF/15387/50020_CE[Ra1]_F[SK]_PF1(JY_SH_KM)_PFA(JY_KM)_PN(KM).pdfhttps://doaj.org/toc/2249-782Xhttps://doaj.org/toc/0973-709XIntroduction: In India, the routine Active Management of ThirdStage of Labour (AMTSL) with conventional intramuscular oxytocin, at the rural, resource-constrained areas, is often compromised due to lack of trained healthcare personnel and proper maintenance of cold chain system, causing maternal mortality and morbidity from Postpartum Haemorrhage (PPH). In these scenarios, tablet misoprostol, can be efficacious and convenient alternative. Aim: To evaluate efficacy and safety of misoprostol administered per rectum with respect to intramuscular oxytocin for effective control of PPH in a Randomised Controlled Trial (RCT). Materials and Methods: In this RCT, conducted in Sambhunath Pandit Hospital, kolkata, West Bengal, India from September 2015 to August 2016, total 80 eligible pregnant mothers in normal labour with prior consent and fulfilled criteria, were allocated to two separated groups (n=40) by computer generated randomisation table. Control group received 10 IU injection oxytocin and case group received 600 μg misoprostol tablet per rectally within one minute of cord clamping and cutting. The primary outcome measures were mean thirdstage and mean postpartum blood loss up to eight hours after delivery. Secondary outcome variables were Mean Arterial Pressure (MAP) after eight hours postdelivery, haemoglobin and haematocrit after 24 hours of delivery and reported side effects. Data was entered into a Microsoft excel spreadsheet and statistical analysis was done by Statistical Package for the Social Sciences (SPSS) version 20.0.1 and Graph Pad Prism version 5.0. Results: Total sample size was 80 equally divided into two groups, with a mean age of 23.20±3.1558 years and 23.7750±3.8927 years in case and control group respectively. The mean third-stage blood loss (332.4105±72.6632 mL versus {vs} 329.0088±59.4503 mL, p=0.8193) and mean total blood loss (426.5575±80.0215 mL vs 424.8783±61.5808 mL, p=0.9165) were statistically indifferent between misoprostol and oxytocin groups by two-sample t-tests. The mean for eight hours postpartum MAP (p=0.0894), 24 hours postpartum haemoglobin (p=0.4534) and haematocrit (p=0.1325) were statistically insignificant between the two groups by twosample t-tests. Incidence of adverse effects like shivering, diarrhoea, compared by Pearson’s Chi-square test, were found to be more but non significant in misoprostol group. Conclusion: This study concludes that per-rectal misoprostol is equally effective as intramuscular oxytocin to control PPH without significant adverse effects.Sougata Kumar BurmanRitwik SamantaKumari Kanak LataJayeeta MukherjeeTapan Kumar DeyJCDR Research and Publications Private Limitedarticleactive management of third-stage of labourresource-constraintssafetyuterotonicsMedicineRENJournal of Clinical and Diagnostic Research, Vol 15, Iss 9, Pp QC09-QC13 (2021)
institution DOAJ
collection DOAJ
language EN
topic active management of third-stage of labour
resource-constraints
safety
uterotonics
Medicine
R
spellingShingle active management of third-stage of labour
resource-constraints
safety
uterotonics
Medicine
R
Sougata Kumar Burman
Ritwik Samanta
Kumari Kanak Lata
Jayeeta Mukherjee
Tapan Kumar Dey
Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
description Introduction: In India, the routine Active Management of ThirdStage of Labour (AMTSL) with conventional intramuscular oxytocin, at the rural, resource-constrained areas, is often compromised due to lack of trained healthcare personnel and proper maintenance of cold chain system, causing maternal mortality and morbidity from Postpartum Haemorrhage (PPH). In these scenarios, tablet misoprostol, can be efficacious and convenient alternative. Aim: To evaluate efficacy and safety of misoprostol administered per rectum with respect to intramuscular oxytocin for effective control of PPH in a Randomised Controlled Trial (RCT). Materials and Methods: In this RCT, conducted in Sambhunath Pandit Hospital, kolkata, West Bengal, India from September 2015 to August 2016, total 80 eligible pregnant mothers in normal labour with prior consent and fulfilled criteria, were allocated to two separated groups (n=40) by computer generated randomisation table. Control group received 10 IU injection oxytocin and case group received 600 μg misoprostol tablet per rectally within one minute of cord clamping and cutting. The primary outcome measures were mean thirdstage and mean postpartum blood loss up to eight hours after delivery. Secondary outcome variables were Mean Arterial Pressure (MAP) after eight hours postdelivery, haemoglobin and haematocrit after 24 hours of delivery and reported side effects. Data was entered into a Microsoft excel spreadsheet and statistical analysis was done by Statistical Package for the Social Sciences (SPSS) version 20.0.1 and Graph Pad Prism version 5.0. Results: Total sample size was 80 equally divided into two groups, with a mean age of 23.20±3.1558 years and 23.7750±3.8927 years in case and control group respectively. The mean third-stage blood loss (332.4105±72.6632 mL versus {vs} 329.0088±59.4503 mL, p=0.8193) and mean total blood loss (426.5575±80.0215 mL vs 424.8783±61.5808 mL, p=0.9165) were statistically indifferent between misoprostol and oxytocin groups by two-sample t-tests. The mean for eight hours postpartum MAP (p=0.0894), 24 hours postpartum haemoglobin (p=0.4534) and haematocrit (p=0.1325) were statistically insignificant between the two groups by twosample t-tests. Incidence of adverse effects like shivering, diarrhoea, compared by Pearson’s Chi-square test, were found to be more but non significant in misoprostol group. Conclusion: This study concludes that per-rectal misoprostol is equally effective as intramuscular oxytocin to control PPH without significant adverse effects.
format article
author Sougata Kumar Burman
Ritwik Samanta
Kumari Kanak Lata
Jayeeta Mukherjee
Tapan Kumar Dey
author_facet Sougata Kumar Burman
Ritwik Samanta
Kumari Kanak Lata
Jayeeta Mukherjee
Tapan Kumar Dey
author_sort Sougata Kumar Burman
title Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
title_short Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
title_full Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
title_fullStr Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
title_full_unstemmed Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
title_sort prophylactic administration of per rectal misoprostol vs intramuscular injection of oxytocin in third-stage of labour for prevention of postpartum haemorrhage: a randomised controlled trial
publisher JCDR Research and Publications Private Limited
publishDate 2021
url https://doaj.org/article/d721309ec20d4a05bf399ce27b7477d3
work_keys_str_mv AT sougatakumarburman prophylacticadministrationofperrectalmisoprostolvsintramuscularinjectionofoxytocininthirdstageoflabourforpreventionofpostpartumhaemorrhagearandomisedcontrolledtrial
AT ritwiksamanta prophylacticadministrationofperrectalmisoprostolvsintramuscularinjectionofoxytocininthirdstageoflabourforpreventionofpostpartumhaemorrhagearandomisedcontrolledtrial
AT kumarikanaklata prophylacticadministrationofperrectalmisoprostolvsintramuscularinjectionofoxytocininthirdstageoflabourforpreventionofpostpartumhaemorrhagearandomisedcontrolledtrial
AT jayeetamukherjee prophylacticadministrationofperrectalmisoprostolvsintramuscularinjectionofoxytocininthirdstageoflabourforpreventionofpostpartumhaemorrhagearandomisedcontrolledtrial
AT tapankumardey prophylacticadministrationofperrectalmisoprostolvsintramuscularinjectionofoxytocininthirdstageoflabourforpreventionofpostpartumhaemorrhagearandomisedcontrolledtrial
_version_ 1718430526134550528